OncBioMune Pharmaceuticals, Inc 4
4 · OncBioMune Pharmaceuticals, Inc · Filed Apr 20, 2017
Insider Transaction Report
Form 4
Hoverman Daniel S.
Director
Transactions
- Award
Employee Stock Option (right to buy)
2017-04-17+350,000→ 350,000 totalExercise: $0.27From: 2018-04-17Exp: 2027-04-17→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]Shares issued as compensation approved by the Issuer's Board of Directors.